A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, ...
From: redirect.alexa.com
Drug Effective In Treatment of Heavy Psoriasis Patients
Posted by Ruslan Abuzant at 7:32 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment